1 Hour Education Modules

Non-drug and non-opioid therapies should be implemented as the first-line approach to care in patients with chronic non-cancer pain. Only when these approaches have been ineffective, opioid therapies may be considered in a select group of patients as outlined in current Australian guidelines. This module aims to educate GPs about the broad issues about opioid use in society, as well as how to confidently and responsibly manage chronic non-cancer pain using an individualised sociopsychobiomedical approach.

Biosimilar medicines are becoming increasingly available in Australia, but misconceptions surrounding them exist among both patients and prescribers. This activity seeks to support primary care practitioners’ safe and effective use of these medications, and develop patient and prescriber confidence through education and evidence-based decision making.

Atopic dermatitis (also known as atopic eczema) is a common skin condition that often begins in infancy or early childhood, but can also arise in young adults or later in life. This module seeks to assist health professionals effectively manage this condition in the primary care setting, dispelling common misconceptions regarding topical corticosteroids and undertaking patient education to optimise treatment outcomes.

How can we encourage our patients to reach and maintain optimal glycaemic control in type 2 diabetes (T2D)? Often we need to rationalise what’s not working to be able to choose solutions that will work. Join international expert Prof Kamlesh Khunti and two local experts, A/Prof Marg McGIll and Dr Gary Deed in an engaging, interactive, on-demand webinar experience – customised for you.

Sun damage caused by ultraviolet radiation is linked to a number of common conditions such as solar keratosis, skin cancer, and photoaging. This module looks at the prevention, diagnosis, and management of common non-melanoma skin conditions in general practice, and will help GPs identify when a specialist referral is necessary.

ME/CFS is a complex, chronic, debilitating disease with systemic effects, which is estimated to affect up to 250,000 Australians. This module aims to educate GPs and others working in the primary care space about our evolving understanding of ME/CFS as an illness, and looks at some of the myths surrounding diagnosis and treatment.